BIOMAT Database Logo BIOMAT Database Logo

Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study. 1991

S C Erzurum, and J A Leff, and J E Cochran, and L M Ackerson, and S J Szefler, and R J Martin, and G R Cott
National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado.

OBJECTIVE To determine the effect of low-dose methotrexate in asthmatic patients on steroid use, asthma symptom scores, pulmonary function, airway reactivity, blood cellular components, and immunoglobulin E levels. METHODS A randomized, double-blind, parallel, placebo-controlled, 13-week clinical trial with follow-up of patients in an open trial of methotrexate at the conclusion of the double-blind study. METHODS An asthma care outpatient clinic. METHODS From February 1988 to March 1990, 19 patients with severe, steroid-dependent asthma were enrolled in the study. Two of these patients were excluded from analysis. METHODS Patients were administered methotrexate or placebo intramuscularly, to assure complete absorption, once weekly during the 13-week study. RESULTS Patients on methotrexate and placebo both significantly decreased their steroid dose by 39.6% (95% CI, 25.1% to 54.1%, P = 0.001) and 40.2% (CI, 17.9% to 67.4%, P = 0.003), respectively. Pulmonary function did not differ significantly between the methotrexate and placebo groups. In addition, airway reactivity and symptom scores were unchanged on methotrexate or placebo. No significant toxicities were seen during the course of the 13-week blinded study, but one patient on methotrexate and prednisone in the follow-up period developed Pneumocystis carinii pneumonia and died. Despite continuing methotrexate for up to 1 year, and increasing methotrexate to 30 mg weekly, no significant benefit of methotrexate on asthma control could be shown. CONCLUSIONS Our study does not support the use of methotrexate in the treatment of severe asthma.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S C Erzurum, and J A Leff, and J E Cochran, and L M Ackerson, and S J Szefler, and R J Martin, and G R Cott
Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma.
July 1990, Lancet (London, England),
S C Erzurum, and J A Leff, and J E Cochran, and L M Ackerson, and S J Szefler, and R J Martin, and G R Cott
Benefits of low weekly doses of methotrexate in steroid-dependent asthmatic patients. A double-blind, randomized, placebo-controlled study.
March 2006, Respiratory medicine,
S C Erzurum, and J A Leff, and J E Cochran, and L M Ackerson, and S J Szefler, and R J Martin, and G R Cott
Therapeutic trial of tilorone in ALS: lack of benefit in a double-blind, placebo-controlled study.
December 1978, Neurology,
S C Erzurum, and J A Leff, and J E Cochran, and L M Ackerson, and S J Szefler, and R J Martin, and G R Cott
A double-blind, placebo-controlled steroid-sparing study with budesonide Turbuhaler in Japanese oral steroid-dependent asthma patients. Japanese Pulmicort Turbuhaler study group.
September 2000, Respirology (Carlton, Vic.),
S C Erzurum, and J A Leff, and J E Cochran, and L M Ackerson, and S J Szefler, and R J Martin, and G R Cott
Comparison of methotrexate 30 mg per week with placebo in chronic steroid-dependent asthma: a 12-week double-blind, cross-over study.
April 1993, Respiratory medicine,
S C Erzurum, and J A Leff, and J E Cochran, and L M Ackerson, and S J Szefler, and R J Martin, and G R Cott
Double blind, placebo controlled study of nedocromil sodium in asthma.
February 1993, Archives of disease in childhood,
S C Erzurum, and J A Leff, and J E Cochran, and L M Ackerson, and S J Szefler, and R J Martin, and G R Cott
Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial.
May 1999, The Journal of allergy and clinical immunology,
S C Erzurum, and J A Leff, and J E Cochran, and L M Ackerson, and S J Szefler, and R J Martin, and G R Cott
Ketotifen in pollen-induced asthma: a double blind placebo-controlled study.
March 1986, Clinical allergy,
S C Erzurum, and J A Leff, and J E Cochran, and L M Ackerson, and S J Szefler, and R J Martin, and G R Cott
Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
December 2008, Arthritis and rheumatism,
S C Erzurum, and J A Leff, and J E Cochran, and L M Ackerson, and S J Szefler, and R J Martin, and G R Cott
Lack of benefit of clonidine treatment for short stature in a double-blind, placebo-controlled trial.
October 1988, Lancet (London, England),
Copied contents to your clipboard!